HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lindblom, D. Articles by Aberg, B. Search for Related Content PubMed PubMed Citation Articles by Lindblom, D. Articles by Aberg, B.

European Journal of Cardio-Thoracic Surgery, Vol 2, 347-354, Copyright © 1988 by European Association for Cardio-thoracic Surgery

ARTICLES

Long-term clinical results after combined aortic and mitral valve replacement

D Lindblom, U Lindblom and B Aberg
Department of Thoracic Surgery, Karolinska Hospital, Stockholm, Sweden.

The results after 282 consecutive double (aortic & mitral) valve replacements (DVR) are compared with our previously reported experience after mitral (MVR, n = 810) and aortic valve replacement (AVR, n = 1753). All but one patient received Bjork-Shiley valves. The follow-up which closed on August 1, 1985 was 99.3% and covered 16,869 patient- years (mean 6.3 years/patient). Autopsies were performed in 74% of all fatalities. Early mortality rates were identical in the three patient groups, and late mortality did not differ between MVR and DVR patients. The fraction of valve-related mortality was similar in all groups. Anticoagulant-related bleeding was equally common in all patient groups. The incidences of thromboembolism, reoperation and valve failure did not differ between MVR and DVR patients, but were significantly higher than among AVR patients. With the exception of a slightly increased incidence of prosthetic valve endocarditis, the results after DVR equal those after MVR. In cases with severe mitral valve disease but borderline aortic valve disease, primary DVR is clearly justified and eliminates the need for, and risks of, a secondary AVR.

This article has been cited by other articles:

				J. Turina, T. Stark, B. Seifert, and M. Turina Predictors of the Long-Term Outcome After Combined Aortic and Mitral Valve Surgery Circulation, November 9, 1999; 100(90002): II-48 - 53. [Abstract] [Full Text] [PDF]

				X. M. Mueller, H. T. Tevaearai, F. Stumpe, A. P. Fischer, M. Hurni, P. Ruchat, and L. v. Segesser Long-term results of mitral-aortic valve operations J. Thorac. Cardiovasc. Surg., June 1, 1998; 115(6): 1298 - 1302. [Abstract] [Full Text] [PDF]

				A. C. Fiore, M. T. Swartz, T. G. Sharp, K. A. Kesler, H. B. Barner, K. S. Naunheim, G. L. Grunkemeier, D. A. Moroney, and G. C. Kaiser Double-Valve Replacement With Medtronic-Hall or St. Jude Valve Ann. Thorac. Surg., May 1, 1995; 59(5): 1113 - 1119. [Abstract] [Full Text]

				D. Lindblom Valve thrombosis and strut fracture with the Bjork-Shiley valve J. Thorac. Cardiovasc. Surg., July 1, 1994; 108(1): 177 - 178. [Full Text]